Good find, thank you @asxwade - "The peer reviewed research is proving very popular"
Botanix and both of Matthew Callahan, Michael Thurn are mentioned under the Conflict of interest statementConflict of interest statement
The authors declare the following competing interests: M.C. and M.T. are employees of Botanix Inc, who co-funded most of this research. M.A.T.B. consults for Botanix Inc., and is an inventor on several antibiotic patents (unrelated to this work) which are undergoing commercialization
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus, page-646
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
-0.020(5.00%) |
Mkt cap ! $689.3M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 40.0¢ | 38.0¢ | $2.264M | 5.785M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 790722 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.5¢ | 231350 | 4 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |